Experts say that consistency, colour and texture can differ at various stages of a baby's development as well as diet.
JNJ-4804 demonstrated highest rates of clinical and endoscopic outcomes compared to golimumab and guselkumab in patients with ulcerative colitis or Crohn's disease ...